Stockscreener 앱 받기
9.685
10.34%
0.785
전일 마감가:
$8.90
열려 있는:
$9.98
하루 거래량:
295.74K
Relative Volume:
2.82
시가총액:
$262.77M
수익:
-
순이익/손실:
-
주가수익비율:
-
EPS:
-
순현금흐름:
-
1주 성능:
+35.08%
1개월 성능:
-0.10%
6개월 성능:
+0.00%
1년 성능:
+0.00%
1일 변동 폭
$9.26
$10.46
1주일 범위
$6.85
$10.46
52주 변동 폭
$6.85
$18.79
Conexeu Sciences Inc Stock (CNXU) Company Profile
명칭
Conexeu Sciences Inc
전화
604-315-4722
주소
50 WEST LIBERTY STREET, SUITE 880, RENO
Compare CNXU vs VRTX, REGN, ARGX, RVMD, ONC
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CNXU
Conexeu Sciences Inc
|
9.82 | 238.15M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
514.80 | 128.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
810.01 | 82.72B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
989.30 | 53.26B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
213.00 | 43.66B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
360.46 | 39.31B | 5.76B | 514.49M | 1.10B | 4.4813 |
Conexeu Sciences Inc 주식(CNXU)의 최신 뉴스
CNXU : Conexeu Sciences Inc. Key Company Details - Zacks Investment Research
Conexeu Sciences (CNXU) Stock Trends and Sentiment 2026 - marketbeat.com
Top Conexeu Sciences (CNXU) Competitors 2026 - marketbeat.com
Conexeu Sciences (CNXU) investor reports 12.3% stake and warrant-linked shares - Stock Titan
Conexeu Sciences Inc. (CNXU) investor discloses 5.5% stake in Schedule 13G filing - Stock Titan
OnePointTwo Capital Ventures (CNXU) discloses 1.88M-share Conexeu Sciences stake - Stock Titan
Conexeu Sciences (CNXU) Stock Chart and Price History 2026 - marketbeat.com
One Platform, Five Markets: Insights into Conexeu Sciences Inc. - SmallCap Asia
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For - marketscreener.com
Conexeu to Present at 2026 Controversies & Conversations in Laser and Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration - marketscreener.com
Cosmetic Surgery's Next Debate: Rebuild Tissue, Not Fill It - marketscreener.com
Conexeu Highlights ECM-Based Regenerative Platform Ahead of 2026 Aesthetics Symposium - tipranks.com
Conexeu to Present at 2026 Controversies & Conversations in Laser & Cosmetic Surgery Symposium on the Role of the Extracellular Matrix in Tissue Regeneration - The Manila Times
Beyond volume: Conexeu to discuss the body's repair process - Stock Titan
Conexeu Sciences Ord Shs (CNXU) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to earnings forward of Conexeu Sciences Inc. – NASDAQ:CNXU - TradingView
Every Few Decades, Aesthetics Gets a New Category. One Preclinical Company Thinks Its Extra Cellular Matrix Platform Could Create the Next One - Investing News Network
Next GLP-1 Billion-Dollar Market: Fireside Chat with Conexeu Sciences CEO Miles Harrison - IPO Edge
Conexeu Sciences (CNXU) logs $62,725 Rule 506(b) equity issuance for services - Stock Titan
Conexeu Sciences (CNXU) investor Michael G. Wright discloses 12.1% ownership stake - Stock Titan
Short Interest in Conexeu Sciences Inc. (NASDAQ:CNXU) Expands By 357.1% - MarketBeat
CNXU|Conexeu Sciences Ord Shs|Price:8.450|Chg%:-0.540 - TradingKey
Conexeu Sciences Inc. Revenue Breakdown – NASDAQ:CNXU - TradingView
Paisley Capital reports 1.8M-share position in Conexeu Sciences Inc. (CNXU) - Stock Titan
David Robert Bogart Net Worth (2026) - GuruFocus
Ana Lucia Bastiani Posner Net Worth (2026) - GuruFocus
Aaron Solomon Farberg Net Worth (2026) - GuruFocus
Jeffrey Nathan Sharpe Net Worth (2026) - GuruFocus
symbol__ Stock Quote Price and Forecast - CNN
Conexeu Sciences Inc.Common Stock (CNXU) Stock Price, News, Quote & History - FinancialContent
Breakeven Is Near for Pulsar Group plc (LON:PULS) - simplywall.st
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
GLP-1 Aesthetic Care Projected to Reach $2B by 2030 - Stock Titan
CNXU Price Today: Conexeu Sciences Inc. Stock Price, Quote & Chart | MEXC - mexc.co
The GLP-1 Boom Created a $2 Billion Opening in Aesthetics. One Preclinical Biotech Is Building the Product to Fill It. - PR Newswire
A Weight-Loss Revolution Is Reshaping Bodies. This Preclinical Biotech Wants to Build What Comes Next - marketscreener.com
Bullish NeOnc Technologies Holdings Insider Buying Worth US$615.6k Yet To Pay Off - simplywall.st
Conexeu Sciences Launches CXU™ Platform for Injectable Aesthetics - Intellectia AI
Stocks & Markets Podcast: Regenerative Medicine’s Next Leap with Conexeu Sciences CEO - TheStreet Pro
Conexeu targets $2B injectable aesthetics marke... - Pluang
Conexeu Sciences Details Completion Of 12-Month P.R.O.O.F. Preclinical Study For CXU Platform - marketscreener.com
The GLP-1s Are Creating Another Boom, a New $2 Billion Opportunity Exists in Aesthetics. Conexeu Is Building for It - The Manila Times
OneWater Marine Inc. (NASDAQ:ONEW): Is Breakeven Near? - simplywall.st
CNXU Stock Price and Chart — NASDAQ:CNXU - TradingView
Claudia Itze Chavez Munoz Net Worth (2026) - GuruFocus
Michael G. Wright Net Worth (2026) - GuruFocus
April Lynn Burke Net Worth (2026) - GuruFocus
Stephen Douglas Inouye Net Worth (2026) - GuruFocus
Conexeu Sciences (CNXU) Insider Trading Activity 2026 - MarketBeat
Flourish Adoption - AOL.com
CNXU Technical Analysis | Trend, Signals & Chart Patterns - ChartMill
Conexeu Sciences Inc (CNXU) 재무 분석
Conexeu Sciences Inc (CNXU)에 대한 금융 데이터가 없습니다. 더 많은 정보를 위해 다른 주식을 확인해보세요.
매출
순이익
현금흐름
주당 순 이익
2.92%
2.03%
자본화:
|
볼륨(24시간):